MedTrace Logo

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

NCT00329251 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2006-05-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether an immunization schedule is beneficial to HIV-infected patients with CD4 recount over 500 cells/mm3 and undetectable viral load.

Conditions

Interventions

BIOLOGICAL

Hepatitis A

BIOLOGICAL

Hepatitis B

BIOLOGICAL

Influenza

BIOLOGICAL

Pneumococcal

BIOLOGICAL

Tetanus-diphteria

BIOLOGICAL

Varicella

BIOLOGICAL

Measles-Mumps-Rubella

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • José Mª Gatell, MD · Hospital Clínic of Barcelona

  • José Mª Miró, MD · Hospital Clínic of Barcelona

  • José Mª Bayas, MD · Hospital Clínic of Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2006-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00329251 on ClinicalTrials.gov